Preclinical rationale for combined treatments of endocrine therapy with 5-fluorouracil but with neither doxorubicin nor paclitaxel in the treatment of endocrine responsive breast cancer.
Preclinical rationale for combined treatments of endocrine therapy with 5-fluorouracil but with neither doxorubicin nor paclitaxel in the treatment of endocrine responsive breast cancer.
复制标题
内分泌治疗与 5-氟尿嘧啶但既不与阿霉素也不与紫杉醇联合治疗内分泌反应性乳腺癌的临床前基本原理。
DOI：
--
复制
发表时间：
2010
期刊：
影响因子：
--
通讯作者：
et al.
中科院分区：
文献类型：
--
作者：
Kurebayashi J;et al.
